Evidence map›Paper›PMID 38322674›Full record

ArticleWorld journal of clinical cases2024

Gestational diabetes mellitus combined with fulminant type 1 diabetes mellitus, four cases of double diabetes: A case report.

Hui Li, Yun Chai, Wei-Hong Guo, Yu-Meng Huang, Xiao-Na Zhang, Wen-Li Feng, Qing He, Jin Cui, Ming Liu

Abstract readCase Reports
In one paragraph

Article in World journal of clinical cases, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Hui LiDepartment of Endocrinology and Metabolism, Tianjin Medical University General Hospital, Tianjin 300052, China.
Yun ChaiDepartment of Endocrinology and Metabolism, Tianjin Medical University General Hospital, Tianjin 300052, China.
Wei-Hong GuoDepartment of Endocrinology and Metabolism, Tianjin Medical University General Hospital, Tianjin 300052, China.
Yu-Meng HuangDepartment of Endocrinology and Metabolism, Tianjin Medical University General Hospital, Tianjin 300052, China.
Xiao-Na ZhangDepartment of Endocrinology and Metabolism, Tianjin Medical University General Hospital, Tianjin 300052, China.
Wen-Li FengDepartment of Endocrinology and Metabolism, Tianjin Medical University General Hospital, Tianjin 300052, China.
Qing HeDepartment of Endocrinology and Metabolism, Tianjin Medical University General Hospital, Tianjin 300052, China.
Jin CuiDepartment of Endocrinology and Metabolism, Tianjin Medical University General Hospital, Tianjin 300052, China. cuijin2001@163.com.
Ming LiuDepartment of Endocrinology and Metabolism, Tianjin Medical University General Hospital, Tianjin 300052, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundFulminant type 1 diabetes mellitus (FT1DM) that occurs during pregnancy or the perinatal period is known as pregnancy-related FT1DM (PF), always without history of abnormal glucose metabolism. Here, we present four patients who developed FT1DM during treatment but were first diagnosed with gestational diabetes mellitus (GDM). CASE SUMMARY: The clinical data of four patients with GDM combined with FT1DM admitted to our hospital between July 2018 and April 2021 were collected, and the patients and their infants were followed up. All patients were diagnosed with GDM during the second trimester and were treated. The blood glucose level elevated suddenly during the third trimester and then were diagnosed with FT1DM. Two patients had an insulin allergy, and two had symptoms of upper respiratory tract infection before onset. One patient developed ketoacidosis, and three developed ketosis. Two patients had cesarean section deliveries, and two had vaginal deliveries. The growth and development of the infants were normal. C-peptide levels were lower than those at onset, suggesting progressive impairment of islet function. The frequencies of the DRB1 09:01, DQB1 03: 03, DQA1 03:02, DPA1 01:03, DPA1 02:02, DPB1 05:01, DRB4 01:03, G 01:01, and G 01:04 human leukocyte antigen (HLA)-G alleles were high in the present study.

conclusionIn comparison with pregnancy-associated FT1DM (PF), patients with GDM combined with FT1DM had an older age of onset, higher body mass index, slower onset, fewer prodromal symptoms, and less acidosis. The pathogenesis may be due to various factors affecting the already fragile β-cells of GDM patients with genetically susceptible class II HLA genotypes. We speculate that GDM combined with FT1DM during pregnancy, referred to as "double diabetes," is a subtype of PF with its own unique characteristics that should be investigated further.

Indexed as

Case reportDouble diabetesFulminant type 1 diabetes mellitusGestational diabetes mellitusPregnancy-related fulminant type 1 diabetes mellitus

Identifiers

PMID38322674
PMCPMC10841125

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.